Drug – bio-affecting and body treating compositions – Whole live micro-organism – cell – or virus containing – Bacteria or actinomycetales
Reexamination Certificate
1998-06-03
2008-05-20
Saucier, Sandra E. (Department: 1651)
Drug, bio-affecting and body treating compositions
Whole live micro-organism, cell, or virus containing
Bacteria or actinomycetales
C435S252500, C424S093100, C426S071000
Reexamination Certificate
active
07374753
ABSTRACT:
Compositions including a non-pathogenic lactic acid-producing bacteria, such as aBacillusspecies, spores or an extracellular product ofB. coagulans, formulated for oral administration to the intestinal tract for inhibiting bacterial gastrointestinal infections are described. Methods and systems using the compositions for treating gastrointestinal infections, particularly sudden infant death syndrome (SIDS) are also disclosed.
REFERENCES:
patent: 5242938 (1993-09-01), Lam
patent: 5322777 (1994-06-01), Selva et al.
patent: 5785990 (1998-07-01), Langrehr
patent: 5968569 (1999-10-01), Cavadini et al.
patent: 6156333 (2000-12-01), Langrehr
patent: 6461607 (2002-10-01), Farmer
patent: 6849256 (2005-02-01), Farmer
patent: 2005/0100535 (2005-05-01), Farmer et al.
patent: WO 9115199 (1991-10-01), None
patent: WO 96/11014 (1996-04-01), None
Dock, D.B. et al. Biocell. 2004, 28(2), 143-150. (“BioNAN” composition, See p. 145, paragraph 2).
Naruse and Naruse “ATCC 31284” ATCC Global Bioresource Center, Apr. 25, 2007, <http://www.atcc.org/common/catalog
umSearch
umResults.cfm?atccNum=31284> (B. coagulans Hammer=L. sporogenes).
Langhendries et al. J. Ped. Gastroent. Nutr.(1995) 21, 177-181.
Green, A.D., “Minimizing the Risk of SIDS” DrGreene.com, Sep. 2004, ,<http://www.drgreene.com/21—509.html>.
Lindsay, J.A.,Crit. Rev. Microbiol., 22(4):257-277 (1966).
Morris, et al.,Med. Hypotheses, 22(2):211-222 (1987).
Murrell, et al.,J. Med. Microbiol., 39(2):114-127 (1993).
Nakamura, et al.,Intl. J. Systematic Bacteriol., No. 1, pp. 63-73 (1988).
Reid, et al.,Clin. Microbiol. Rev., 3(4):335-344 (1990).
Supplementary European Search Report for EP 98 92 5189, date of mailing: Jan. 14, 2004.
Farmer Sean
Mikhail Robert J.
Beattie Ingrid A.
Ganeden Biotech, Inc.
Kosar Aaron J
Mintz Levin Cohn Ferris Glovsky and Popeo P.C.
Saucier Sandra E.
LandOfFree
Probiotic lactic acid bacterium to treat bacterial... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Probiotic lactic acid bacterium to treat bacterial..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Probiotic lactic acid bacterium to treat bacterial... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3983087